Patents by Inventor Bryan Traynor

Bryan Traynor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DIAGNOSING A NEURODEGENERATIVE DISEASE
    Publication number: 20180187262
    Abstract: The present disclosure relates to methods of assessing whether a subject has or is likely to develop a neurodegenerative disease including determining whether the subject has a mutation in the C9orf72 gene, wherein said mutation prevents or disrupts C9orf72 expression relative to expression in a reference from subjects without the mutation.
    Type: Application
    Filed: December 29, 2017
    Publication date: July 5, 2018
    Inventors: Stuart Pickering-Brown, Bryan Traynor, Andrew B. Singleton, Huw Morris, Peter Heutink, John Hardy, Pentti Tienari
  • Method for diagnosing a neurodegenerative disease
    Patent number: 9896729
    Abstract: The present invention relates to methods of assessing whether a subject has or is likely to develop a neurodegenerative disease comprising determining whether the subject has a mutation in the C9orf72 gene wherein said mutation prevents or disrupts C9orf72 expression relative to expression in a reference from subjects without the mutation.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: February 20, 2018
    Assignees: The University of Manchester, National Institute of Aging, Hospital District of Helsinki and UUSIMAA, VU University Medical Centre Armsterdam, UCL Business PLC, University College Cardiff Consultants Limited
    Inventors: Stuart Pickering-Brown, Bryan Traynor, Andrew B. Singleton, Huw Morris, Peter Heutink, John Hardy, Pentti Tienari
  • METHOD FOR DIAGNOSING A NEURODEGENERATIVE DISEASE
    Publication number: 20150252421
    Abstract: The present invention relates to methods of assessing whether a subject has or is likely to develop a neurodegenerative disease comprising determining whether the subject has a mutation in the C9orf72 gene wherein said mutation prevents or disrupts C9orf72 expression relative to expression in a reference from subjects without the mutation.
    Type: Application
    Filed: August 31, 2012
    Publication date: September 10, 2015
    Applicants: THE UNIVERSITY OF MANCHESTER, NATIONAL INSTITUTE ON AGING, HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA, VU UNIVERSITY MEDICAL CENTRE AMSTERDAM, UCL BUSINESS PLC, UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Stuart Pickering-Brown, Bryan Traynor, Andrew B. Singleton, Huw Morris, Peter Heutink, John Hardy, Pentti Tienari